1988
DOI: 10.1016/s0272-6386(88)80154-9
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-γ (IFN-γ) as In Vitro Enhancing Factor of Peritoneal Macrophage Defective Bactericidal Activity During Continuous Ambulatory Peritoneal Dialysis (CAPD)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0

Year Published

1989
1989
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(9 citation statements)
references
References 17 publications
2
7
0
Order By: Relevance
“…Also, the PMf from such patients are less efficient in generating and in killing S. epidermidis, and they display a reduced membrane Fc receptor number. These findings are in accord with the results of previous studies showing that peritoneal cells from these patients do not function as well as those obtained from patients with a low incidence of peritonitis (15); however, they conflict with those of others (9) who found the peritoneal immune cell functions in patients undergoing CAPD to be near normal, without taking into account the frequency of peritonitis in such patients. We found that PLy and PM4 taken from high-peritonitisincidence CAPD patients, when incubated in vitro with increasing concentrations of MPL, are able to regain a satisfactory ability to release cytokines.…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…Also, the PMf from such patients are less efficient in generating and in killing S. epidermidis, and they display a reduced membrane Fc receptor number. These findings are in accord with the results of previous studies showing that peritoneal cells from these patients do not function as well as those obtained from patients with a low incidence of peritonitis (15); however, they conflict with those of others (9) who found the peritoneal immune cell functions in patients undergoing CAPD to be near normal, without taking into account the frequency of peritonitis in such patients. We found that PLy and PM4 taken from high-peritonitisincidence CAPD patients, when incubated in vitro with increasing concentrations of MPL, are able to regain a satisfactory ability to release cytokines.…”
Section: Discussionsupporting
confidence: 86%
“…This is accompanied by an increase in the number of PMX Fc receptors and in PMX bactericidal capacity. This effect of MPL on peritoneal immune cell functions has some analogy with that observed in animals and humans seen by incubating PM4X with IFN-y (12,15,29).…”
Section: Discussionsupporting
confidence: 61%
“…Lower amounts of IFN‐ γ released by peritoneal lymphocytes from PD patients with high peritonitis incidence in comparison with patients with low peritonitis incidence and healthy people has been reported by Lamperi et al . [40]. The bacterial killing of peritoneal macrophages improved after treatment with IFN‐ γ .…”
Section: Discussionmentioning
confidence: 99%
“…Previous reports described that peritonitis in PD patients is predominantly a type 1 immune response characterized by the early induction of TNF-α, IL-1β, IL-12, and IL-18, followed by elevated levels of IFN-γ [ 2 , 38 ]. The presence of a Th1 phenotype in peritoneal effluents seems to lower the risk of peritonitis [ 4 , 20 ]. These findings suggested that peritoneal Th1 cells may improve cooperation among T cells, peritoneal macrophages, and peritoneal mesothelial cells.…”
Section: Discussionmentioning
confidence: 99%